佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01466 佰金生命科学

未开盘 12-05 15:50:46

0.510

+0.010

+2.00%

最高0.510	最低0.480	成交量83.20万
今开0.500	昨收0.500	日振幅6.00%
总市值4.75亿	流通市值4.75亿	总股本9.32亿
成交额40.80万	换手率0.09%	流通股本9.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01466","market":"HK","secType":"STK","nameCN":"佰金生命科学","latestPrice":0.51,"timestamp":1764921046730,"preClose":0.5,"halted":0,"volume":832000,"delay":0,"floatShares":932000000,"shares":932000000,"eps":-0.000455,"marketStatus":"未开盘","change":0.01,"latestTime":"12-05 15:50:46","open":0.5,"high":0.51,"low":0.48,"amount":408000,"amplitude":0.06,"askPrice":0.51,"askSize":32000,"bidPrice":0.49,"bidSize":32000,"shortable":0,"etf":0,"ttmEps":0.010018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1413475200000,"exchange":"SEHK","adjPreClose":0.5,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":2.2807017553237534,"lotSize":32000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01466","defaultTab":"news","newsList":[{"id":"2588728206","title":"佰金生命科学(01466)附属与谷环医疗签订策略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2588728206","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588728206?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:13","pubTimestamp":1764580437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学 发布公告，公司间接全资附属公司北京佰金生物科技有限公司与上海谷环医疗器械有限公司签订策略合作框架协议，据此，北京佰金将透过认购股权的方式对谷环医疗进行投资，旨在构建集团品牌医疗产品直营门店销售渠道。同时，将会拟任命梁亮先生为集团医疗事业部总监，负责医疗产品拓展工作。合作框架协议将于2026年12月31日届满，协议任何一方均可提前 10天通知另一方提前终止合作框架协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","159891","BK1227"],"gpt_icon":0},{"id":"2588748626","title":"佰金生命科学(01466)根据一般授权发行4000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588748626","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588748626?lang=zh_cn&edition=full","pubTime":"2025-12-01 11:44","pubTimestamp":1764560696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，于2025年11月28日根据公司股东于2024年9月30日批准的一般授权发行4000万股新股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2586244873","title":"佰金生命科学(01466)公布中期业绩 拥有人应占溢利217.3万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2586244873","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586244873?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:48","pubTimestamp":1764240519,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)公布截至2025年9月30日止六个月的中期业绩，收入为5514.5万港元，同比减少22.22%;公司拥有人应占溢利217.3万港元，同比扭亏为盈;每股盈利0.28港仙。公告称，扭亏为盈主要由于可换股债券的公平值变动收益及毛利的减幅被抵销所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"1161104659","title":"佰金生命科学2025年中期财报：净利润250万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161104659","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161104659?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:38","pubTimestamp":1764059884,"startTime":"0","endTime":"0","summary":"本季度信息\n佰金生命科学控股有限公司（股份代号：1466）公告，截至2025年9月30日止六个月，公司经调整后净利润约为250万港元，而去年同期（截至2024年9月30日止六个月）净亏损约190万港元，实现同比扭亏为盈。公告显示，此次净利润增长主要由于可换股债券公平值变动带来的收益，同时受到毛利减少部分的抵销影响。公司计划于2025年11月27日正式公布中期业绩，相关数据仍待最终审阅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466"],"gpt_icon":0},{"id":"2586134428","title":"佰金生命科学(01466)发盈喜 预计中期纯利约250万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586134428","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586134428?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:36","pubTimestamp":1764059761,"startTime":"0","endTime":"0","summary":"佰金生命科学(01466)发布公告，集团预期截至2025年9月30日止六个月将取得...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2584891934","title":"佰金生命科学(01466)附属拟入股投资优环生物 打造全球领先的环状RNA(circ RNA)技术研发平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2584891934","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584891934?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:36","pubTimestamp":1763541371,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学 公布，公司间接全资附属公司北京佰金生物科技有限公司与优环(苏州)生物医药科技有限公司签订策略合作框架协议，据此，北京佰金将透过认购优环生物股权的方式对优环生物进行投资，旨在打造全球领先的环状RNA技术研发平台并借助此平台，深化细胞治疗领域的技术创新。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK1227","BK4588","RNA","BK4505","BK4585","01466","IE0009354923.USD"],"gpt_icon":0},{"id":"2584667755","title":"佰金生命科学11月27日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2584667755","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584667755?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:39","pubTimestamp":1763368797,"startTime":"0","endTime":"0","summary":"格隆汇11月17日丨佰金生命科学(01466.HK)宣布，公司将于2025年11月27日(星期四)举行董事会会议，藉以(其中包括)批准公司及其附属公司截至2025年9月30日止六个月的未经审核中期业绩公告，以及考虑派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117164012a4a731a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117164012a4a731a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2573405949","title":"佰金生命科学(01466)因转换可换股债券发行1.199亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2573405949","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573405949?lang=zh_cn&edition=full","pubTime":"2025-10-08 17:26","pubTimestamp":1759915561,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，于2025年9月29日，公司收到债券持有人发出的转换通知，内容有关按换股价每股换股股份0.2628港元行使本金额为3150万港元的可换股债券所附带换股权。因此，1.199亿股换股股份(相当于公司现有已发行股本约15.52%及公司经发行换股股份扩大后的已发行股本约13.43%)已于2025年10月8日配发及发行予债券持有人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2571862333","title":"佰金生命科学(01466)拟折让约14.29%发行4000万股认购股份 净筹约1910万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571862333","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571862333?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:05","pubTimestamp":1759147515,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)公布，于2025年9月29日( 联交所交易时段后 )，公司( 作为发行人 )与认购人各自订立认购协议，以按认购价每股股份0.48港元认购合共4000万股认购股份。认购价较股份于2025年9月29日( 即认购协议日期 )在联交所所报收市价每股0.56港元折让约14.29 %。认购事项净筹约1910万港元，拟用作集团的一般营运资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"1195322203","title":"佰金生命科学签署认购协议 总计4000万股认购股份 每股0.48港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195322203","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195322203?lang=zh_cn&edition=full","pubTime":"2025-09-29 19:59","pubTimestamp":1759147153,"startTime":"0","endTime":"0","summary":"佰金生命科学宣布已签署认购协议，涉及总计4000万股认购股份，每股认购价格为0.48港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2554497917","title":"佰金生命科学(01466)7月28日起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2554497917","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554497917?lang=zh_cn&edition=full","pubTime":"2025-07-28 08:56","pubTimestamp":1753664194,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，该公司的股份将于2025年7月28日上午9时正起恢复买卖。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1227","01466"],"gpt_icon":0},{"id":"2554749082","title":"佰金生命科学今早复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2554749082","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554749082?lang=zh_cn&edition=full","pubTime":"2025-07-28 08:52","pubTimestamp":1753663951,"startTime":"0","endTime":"0","summary":"格隆汇7月28日丨佰金生命科学(01466.HK)发布公告，该公司的股份将于今天(28/7/2025)上午九时正起恢复买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072808523597221075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072808523597221075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2554795639","title":"佰金生命科学(01466)发布年度业绩 股东应占亏损31.6万港元 同比收窄95.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554795639","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554795639?lang=zh_cn&edition=full","pubTime":"2025-07-25 23:04","pubTimestamp":1753455898,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布截至2025年3月31日止年度业绩，该集团期内取得收入1.36亿港元，同比增加152.54%;公司拥有人应占亏损31.6万港元，同比收窄95.76%;每股基本亏损0.05港仙。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2553200993","title":"佰金生命科学(01466)预期年度亏损同比减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2553200993","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553200993?lang=zh_cn&edition=full","pubTime":"2025-07-24 19:57","pubTimestamp":1753358258,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，本集团预期截至2025年3月31日止年度将取得亏损约10万港元，而截至2024年3月31日止年度则取得亏损约为850万港元。亏损大幅减少主要由于下列因素：收益及毛利增长，主要来自珠宝业务分部; 应收货款及其他应收账款的预期信贷亏损拨备拨回净额增加;其他收益净额增加;及经抵销商誉减值亏损及行政开支增加。此外，继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2548831079","title":"佰金生命科学(01466)自7月2日起暂停买卖 待刊发2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2548831079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548831079?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:09","pubTimestamp":1751418585,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，应公司要求，公司股份将自2025年7月2日上午九时正起于联交所暂停买卖，以待刊发2025年度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2547093071","title":"佰金生命科学(01466)：谢春辰已获委任为董事会提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2547093071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547093071?lang=zh_cn&edition=full","pubTime":"2025-06-30 19:04","pubTimestamp":1751281455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，现任非执行董事谢春辰已获委任为董事会提名委员会成员，自2025年6月30日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2546211694","title":"佰金生命科学：延迟刊发2025年度业绩及暂停买卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2546211694","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546211694?lang=zh_cn&edition=full","pubTime":"2025-06-25 18:31","pubTimestamp":1750847503,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯6月25日，佰金生命科学公告，由于附属公司管理层变更后的交接过程较预期耗时更长，且公司于本周初方全面控制附属公司的运营，故截至2025年3月31日止年度之年度业绩将延迟刊发。核数师及公司需要更多时间以编制2025年度业绩。预计2025年度业绩将于2025年7月25日前刊发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202506253440215183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506253440215183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1227","01466"],"gpt_icon":0},{"id":"2545689400","title":"佰金生命科学06月24日主力净流入75.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545689400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545689400?lang=zh_cn&edition=full","pubTime":"2025-06-24 16:15","pubTimestamp":1750752927,"startTime":"0","endTime":"0","summary":"06月24日，佰金生命科学股价收平报0.69元，成交金额156.9万元，换手率0.30%，振幅5.80%，量比4.68。佰金生命科学今日主力资金净流入75.1万元，上一交易日主力净流出0万元。该股主力净额占比0.14%，港股市场排名85/2659。|06月24日主力加仓幅度排名||#|股票简称|主力净额占比|#|中天湖南集团|5.34%|#|浙江世宝|3.55%|#|GBA集团|3.28%|#|...|...|#85|佰金生命科学|0.14%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172438a4bb3127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624172438a4bb3127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1227","01466"],"gpt_icon":0},{"id":"2542687453","title":"佰金生命科学(01466)委任张诗敏和苏耀耀为各香港附属公司的董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2542687453","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542687453?lang=zh_cn&edition=full","pubTime":"2025-06-09 12:38","pubTimestamp":1749443915,"startTime":"0","endTime":"0","summary":"智通财经APP讯，佰金生命科学(01466)发布公告，公司正进行若干附属公司，即汇宝丰投资控股有限公司、民生创见有限公司、荟宝珠饰有限公司、民生珠宝(香港)有限公司及宝荟珠宝有限公司(统称香港附属公司)，以及汇宝丰珠宝(深圳)有限公司(中国附属公司，连同香港附属公司，合称附属公司)的董事及监事变更。上述相关变更包括(i)委任张诗敏和苏耀耀为各香港附属公司的董事;(ii) 别委任李松和苏耀耀为中国附属公司的董事和监事;(iii)罢免各香港附属公司作为唯一董事的陈志伟;及(iv)罢免中国附属公司董事许超生、陈木胜及韩继平及监事熊英(附属公司管理层变更)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01466","BK1227"],"gpt_icon":0},{"id":"2512148178","title":"佰金生命科学盘中异动 早盘股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512148178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512148178?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:30","pubTimestamp":1739928654,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘09时30分，佰金生命科学股票出现异动，股价急速上涨6.00%。佰金生命科学股票所在的其他零售商行业中，整体涨幅为0.00%。其相关个股中，佰金生命科学、六福集团、弥明生活百货涨幅较大，振幅较大的相关个股有周大福、马可数字科技、上美股份，振幅分别为1.14%、0.85%、0.68%。佰金生命科学公司简介：钱唐控股有限公司是一家主要从事采购、加工、设计、生产及批发分销珍珠及珠宝产品的中国香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021909305496281206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021909305496281206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01466","BK1227"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mansangjewellery.com","stockEarnings":[{"period":"1week","weight":-0.1053},{"period":"1month","weight":-0.1207},{"period":"3month","weight":0.0625},{"period":"6month","weight":-0.2714},{"period":"1year","weight":-0.1639},{"period":"ytd","weight":-0.0893}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"佰金生命科学控股有限公司（原名：钱唐控股有限公司）是一间主要从事制造及销售珠宝产品的投资控股公司。该公司通过五个分部运营业务。销售珍珠及珠宝产品分部从事设计及销售珠宝产品以及销售珍珠。品牌营销及咨询服务分部从事按照合约协定的服务条款提供品牌营销及咨询服务。护肤解决方案业务分部从事以品牌FO名称， 透过销售合约向化妆店及医院出售护肤解决方案产品，并透过网上销售平台向个别客户出售护肤解决方案产品。研发服务分部从事提供专业科研服务。策略投资及财务服务分部从事房地产金融资产投资。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.00483},{"month":2,"riseRate":0.272727,"avgChangeRate":0.003741},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.037221},{"month":4,"riseRate":0.545455,"avgChangeRate":0.01499},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.017753},{"month":6,"riseRate":0.272727,"avgChangeRate":0.078182},{"month":7,"riseRate":0.777778,"avgChangeRate":0.168644},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.066372},{"month":9,"riseRate":0.727273,"avgChangeRate":-0.001996},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.032601},{"month":11,"riseRate":0.5,"avgChangeRate":0.074628},{"month":12,"riseRate":0.25,"avgChangeRate":-0.004674}],"exchange":"SEHK","name":"佰金生命科学","nameEN":"BAIJIN LIFE SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佰金生命科学(01466)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佰金生命科学,01466,佰金生命科学股票,佰金生命科学股票老虎,佰金生命科学股票老虎国际,佰金生命科学行情,佰金生命科学股票行情,佰金生命科学股价,佰金生命科学股市,佰金生命科学股票价格,佰金生命科学股票交易,佰金生命科学股票购买,佰金生命科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佰金生命科学(01466)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佰金生命科学(01466)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}